Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2− bone-only metastatic breast cancer

Authors

Institutions

Publication Details

Journal
The Breast
Published
2026-02-25
DOI
https://doi.org/10.1016/j.breast.2026.104744
Primary Topic
Advanced Breast Cancer Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2− bone-only metastatic breast cancer

A Brufsky, Melissa Soria Estévez, Rachel M. Layman, Paul Cottu et al.
The Breast
Advanced Breast Cancer Therapies
article

Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2− bone-only metastatic breast cancer

A Brufsky, Melissa Soria Estévez, Rachel M. Layman, Paul Cottu, Aaron Cohen, Benjamin Li, Hope S. Rugo, Giuseppe Curigliano, Lynn McRoy, Xianchen Liu
article en

Abstract

No abstract available for this paper.
The BreastVol. 86
The University of Texas MD Anderson Cancer Center (US), Pfizer (United States) (US), Université Paris Cité (FR), City of Hope (US), University of Pittsburgh Medical Center (US), Flatiron Health (United States) (US), European Institute of Oncology (IT), Institut Curie (FR)
Good health and well-being
Openalex Percentile: Top 44%
Advanced Breast Cancer Therapies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.